T. Rowe Price Associates’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $494M | Buy |
7,873,368
+416,082
| +6% | +$33.3M | 0.06% | 253 |
|
|
2025
Q4 | $711M | Sell |
7,457,286
-920,040
| -11% | -$90.2M | 0.08% | 196 |
|
|
2025
Q3 | $818M | Sell |
8,377,326
-2,643,954
| -24% | -$274M | 0.09% | 187 |
|
|
2025
Q2 | $1.18B | Buy |
11,021,280
+410,793
| +4% | +$41.6M | 0.13% | 147 |
|
|
2025
Q1 | $1.07B | Buy |
10,610,487
+1,664,108
| +19% | +$168M | 0.13% | 152 |
|
|
2024
Q4 | $799M | Buy |
8,946,379
+695,000
| +8% | +$61.2M | 0.09% | 195 |
|
|
2024
Q3 | $691M | Buy |
8,251,379
+180,326
| +2% | +$14.2M | 0.08% | 228 |
|
|
2024
Q2 | $622M | Buy |
8,071,053
+888,893
| +12% | +$65.1M | 0.07% | 229 |
|
|
2024
Q1 | $492M | Buy |
7,182,160
+878,404
| +14% | +$56.5M | 0.06% | 275 |
|
|
2023
Q4 | $364M | Buy |
6,303,756
+516,386
| +9% | +$27.6M | 0.05% | 302 |
|
|
2023
Q3 | $306M | Buy |
5,787,370
+1,195,590
| +26% | +$62.7M | 0.04% | 318 |
|
|
2023
Q2 | $248M | Buy |
4,591,780
+560,880
| +14% | +$29.3M | 0.03% | 359 |
|
|
2023
Q1 | $202M | Buy |
4,030,900
+1,663,351
| +70% | +$78.4M | 0.03% | 382 |
|
|
2022
Q4 | $110M | Buy |
2,367,549
+517,236
| +28% | +$22.4M | 0.02% | 472 |
|
|
2022
Q3 | $71.7M | Buy |
1,850,313
+7,738
| +0.4% | +$310K | 0.01% | 556 |
|
|
2022
Q2 | $68.7M | Sell |
1,842,575
-194,886
| -10% | -$7.93M | 0.01% | 780 |
|
|
2022
Q1 | $90.2M | Sell |
2,037,461
-3,778,489
| -65% | -$164M | 0.01% | 758 |
|
|
2021
Q4 | $247M | Sell |
5,815,950
-19,329
| -0.3% | -$812K | 0.02% | 502 |
|
|
2021
Q3 | $253M | Sell |
5,835,279
-390,328
| -6% | -$17.3M | 0.02% | 472 |
|
|
2021
Q2 | $266M | Sell |
6,225,607
-289,028
| -4% | -$12.2M | 0.02% | 479 |
|
|
2021
Q1 | $252M | Sell |
6,514,635
-7,747,002
| -54% | -$293M | 0.03% | 488 |
|
|
2020
Q4 | $513M | Sell |
14,261,637
-27,915,803
| -66% | -$1.01B | 0.05% | 323 |
|
|
2020
Q3 | $1.61B | Buy |
42,177,440
+13,594,354
| +48% | +$524M | 0.19% | 114 |
|
|
2020
Q2 | $1B | Buy |
28,583,086
+11,640,875
| +69% | +$419M | 0.13% | 170 |
|
|
2020
Q1 | $553M | Buy |
16,942,211
+835,933
| +5% | +$32.7M | 0.09% | 242 |
|
|
2019
Q4 | $728M | Sell |
16,106,278
-1,354,314
| -8% | -$56.7M | 0.09% | 227 |
|
|
2019
Q3 | $710M | Buy |
17,460,592
+3,711,940
| +27% | +$157M | 0.1% | 215 |
|
|
2019
Q2 | $591M | Buy |
13,748,652
+3,039,311
| +28% | +$117M | 0.08% | 252 |
|
|
2019
Q1 | $411M | Buy |
10,709,341
+1,593,030
| +17% | +$60.8M | 0.06% | 298 |
|
|
2018
Q4 | $322M | Buy |
9,116,311
+1,089,045
| +14% | +$39.5M | 0.05% | 318 |
|
|
2018
Q3 | $309M | Buy |
8,027,266
+2,261,008
| +39% | +$79M | 0.05% | 380 |
|
|
2018
Q2 | $189M | Buy |
5,766,258
+3,407,385
| +144% | +$103M | 0.03% | 493 |
|
|
2018
Q1 | $64.4M | Sell |
2,358,873
-2,303,102
| -49% | -$62.6M | 0.01% | 787 |
|
|
2017
Q4 | $116M | Buy |
4,661,975
+2,254,532
| +94% | +$62.2M | 0.02% | 593 |
|
|
2017
Q3 | $70.2M | Sell |
2,407,443
-98,245
| -4% | -$2.71M | 0.01% | 735 |
|
|
2017
Q2 | $69.5M | Sell |
2,505,688
-46,495
| -2% | -$1.23M | 0.01% | 716 |
|
|
2017
Q1 | $63.5M | Sell |
2,552,183
-7,190
| -0.3% | -$175K | 0.01% | 726 |
|
|
2016
Q4 | $55.4M | Sell |
2,559,373
-1,900
| -0.1% | -$41.5K | 0.01% | 777 |
|
|
2016
Q3 | $61M | Buy |
2,561,273
+57,610
| +2% | +$1.37M | 0.01% | 730 |
|
|
2016
Q2 | $58.5M | Buy |
2,503,663
+57,620
| +2% | +$1.25M | 0.01% | 723 |
|
|
2016
Q1 | $46M | Sell |
2,446,043
-1,100
| -0% | -$19.3K | 0.01% | 797 |
|
|
2015
Q4 | $45.1M | Buy |
2,447,143
+17,100
| +0.7% | +$306K | 0.01% | 799 |
|
|
2015
Q3 | $39.9M | Buy |
2,430,043
+72,200
| +3% | +$1.23M | 0.01% | 856 |
|
|
2015
Q2 | $41.7M | Buy |
2,357,843
+36,350
| +2% | +$650K | 0.01% | 903 |
|
|
2015
Q1 | $41.2M | Buy |
2,321,493
+92,030
| +4% | +$1.45M | 0.01% | 898 |
|
|
2014
Q4 | $29.5M | Sell |
2,229,463
-3,094,370
| -58% | -$39.6M | 0.01% | 1019 |
|
|
2014
Q3 | $62.9M | Sell |
5,323,833
-23,100
| -0.4% | -$291K | 0.01% | 751 |
|
|
2014
Q2 | $68.3M | Sell |
5,346,933
-117,520
| -2% | -$1.53M | 0.01% | 757 |
|
|
2014
Q1 | $73.9M | Buy |
5,464,453
+677,000
| +14% | +$8.89M | 0.02% | 724 |
|
|
2013
Q4 | $57.5M | Sell |
4,787,453
-8,567,200
| -64% | -$101M | 0.01% | 786 |
|
|
2013
Q3 | $157M | Buy |
13,354,653
+3,990,100
| +43% | +$43.2M | 0.04% | 465 |
|
|
2013
Q2 | $86.8M | Buy |
+9,364,553
| New | +$79.4M | 0.02% | 614 |
|
Other funds holding BSX
VCM
VPM
T. Rowe Price Associates's BSX Position: Q1 2026 in Review
T. Rowe Price Associates increased its Boston Scientific (BSX) stake by 5.6% in Q1 2026, buying an estimated $33.3M and bringing the position to 7,873,368 shares worth $494M. The position accounts for 0.06% of the portfolio, ranked #253.
T. Rowe Price Associates first reported a position in BSX in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.61B in Q3 2020. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.
- T. Rowe Price Associates held 7,873,368 shares of Boston Scientific worth $494M as of Q1 2026.
- T. Rowe Price Associates bought 416,082 Boston Scientific shares in Q1 2026, an estimated $33.3M.
- Boston Scientific made up 0.06% of T. Rowe Price Associates's portfolio in Q1 2026, its #253 holding.
- T. Rowe Price Associates first reported a position in Boston Scientific in Q2 2013 and has held it in 52 quarters since.
- T. Rowe Price Associates's Boston Scientific position peaked at $1.61B in Q3 2020.
- 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.